Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Rectal Neoplasms 5Prostatic Neoplasms 4Endometrial Neoplasms 4Colorectal Neoplasms 3Colonic Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thymoma 2Obesity, Morbid 2Neoplasms 2Kidney Neoplasms 2Genital Diseases, Female 2Esophageal Neoplasms 2Uterine Prolapse 1Uterine Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Diseases 1Precancerous Conditions 1Pelvic Organ Prolapse 1Pancreatic Neuroendocrine Tumors 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Myasthenia Gravis 1Menstruation Disturbances 1Mediastinal Neoplasms 1Lymphatic Metastasis 1

Interventions

Rocuronium 1Robotic Surgical Procedures 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Prolapse × Robotic Surgical Procedures × Clear all
NCT07120945 2026-03-06

Embrace Gyn

Medtronic - MITG

Phase NA Recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡